Daniel P Radin (Daniel Radin, Radin Dp)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Drug Administration

Cancer Stem Cells

Top Venues

The Journal of pharmacology and experimental therapeutics

Synapse (New York, N.Y.)

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sheng Zhong, Rok Cerne, Mohammed Shoaib, Jeffrey M Witkin, Arnold Lippa
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763. Future medicinal chemistry (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, S Zhong, Rok Cerne, Jeffrey Witkin, A Lippa
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkines. Synapse (New York, N.Y.) 78 (5) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Daniel P Radin, Sophie G Shifman, Ian R Outhwaite, Aryan Sharma, Robert Bases, Markus A Seeliger, Stella E Tsirka
Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo. The Journal of pharmacology and experimental therapeutics 389 (1) (2024)
Michael D Caponegro, Ki Oh, Miguel M Madeira, Daniel P Radin, Nicholas Sterge, Maryam Tayyab, Richard A Moffitt, Stella E Tsirka
A distinct microglial subset at the tumor-stroma interface of glioma. Glia 69 (7) (2021)